Related Experiment Video
Updated: May 30, 2026

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
Published on: November 25, 2025
Multiple endocrine responses to clonidine in obsessive compulsive dissorder
S Khanna1, P L Reddy, M N Subhash
1Sumant Khanna, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore - 560 029.
This study found significant neuroendocrine disturbances in patients with obsessive-compulsive disorder (OCD), including abnormal growth hormone, cortisol, and ACTH release in response to clonidine.
Area of Science:
- Neuroendocrinology
- Psychiatry
Background:
- Obsessive-compulsive disorder (OCD) is a complex mental health condition.
- Neuroendocrine system dysregulation may play a role in OCD pathophysiology.
Purpose of the Study:
- To investigate neuroendocrine responses to clonidine in individuals with OCD compared to healthy controls.
- To explore potential noradrenergic and serotonergic dysfunction in OCD.
Main Methods:
- Seventy-two subjects diagnosed with OCD and 18 healthy volunteers were administered clonidine.
- Multiple neuroendocrine responses, including growth hormone, cortisol, and ACTH release, were measured.
Main Results:
- Significant heterogeneity was observed in growth hormone responses among OCD subjects.
- Disturbances in cortisol and ACTH release were significantly noted in the OCD group.
Conclusions:
- The findings suggest significant neuroendocrine abnormalities in OCD.
- An interactional model involving noradrenergic and serotonergic systems is proposed to explain OCD pathology.
Related Concept Videos
Obsessive-Compulsive Disorder
Cushing Syndrome II: Pathophysiology
Cushing Syndrome I: Introduction
Desensitization and Tachyphylaxis
Several...
Antidepressant Drugs: MAOIs and Other Agents
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...

